InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in InflaRx N.V. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q2 2021
- Shares held
- 8.88M
- −2.11M (−19.2%) vs. Q2 2021
- Total value
- $23.0M
- −$9.64M (−29.5%) vs. Q2 2021
- New holders
- 6
- 5 more added
- Sold out
- 7
- 11 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $211.6M |
| Q1 2026 | 35 | $16.9M |
| Q4 2025 | 34 | $19.6M |
| Q3 2025 | 27 | $24.9M |
| Q2 2025 | 27 | $13.3M |
| Q1 2025 | 31 | $17.9M |
| Q4 2024 | 30 | $32.1M |
| Q3 2024 | 27 | $19.7M |
| Q2 2024 | 33 | $23.0M |
| Q1 2024 | 37 | $21.3M |
| Q4 2023 | 39 | $27.8M |
| Q3 2023 | 42 | $56.8M |
| Q2 2023 | 37 | $82.7M |
| Q1 2023 | 25 | $7.08M |
| Q4 2022 | 33 | $11.6M |
| Q3 2022 | 30 | $10.5M |
| Q2 2022 | 27 | $7.63M |
| Q1 2022 | 32 | $12.0M |
| Q4 2021 | 38 | $44.1M |
| Q3 2021 | 35 | $23.0M |
| Q2 2021 | 37 | $33.1M |
| Q1 2021 | 42 | $56.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding InflaRx N.V.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 2 | $0 | 0.00% | −28−93.3% | Reduced |
| Harbour Investments, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 609 | $2.00K | 0.00% | +609 | New |
| Royal Bank of Canada | 776 | $2.00K | 0.00% | +776 | New |
| Simplex Trading, LLC | 3,846 | $11.0K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 4,800 | $12.0K | 0.00% | +3,600+300.0% | Added |
| UBS Group AG | 5,015 | $13.0K | 0.00% | +3,770+302.8% | Added |
| BlackRock Inc. | 7,419 | $19.0K | 0.00% | 00.0% | Unchanged |
| Raymond James & Associates | 10,419 | $27.0K | 0.00% | −9,500−47.7% | Reduced |
| Occudo Quantitative Strategies LP | 10,548 | $27.0K | 0.00% | −214−2.0% | Reduced |
| Two Sigma Investments, LP | 11,070 | $29.0K | 0.00% | +11,070 | New |
| Raymond James Financial Services Advisors, Inc. | 13,888 | $36.0K | 0.00% | −9,458−40.5% | Reduced |
| ETF Managers Group, LLC | 16,134 | $42.0K | 0.00% | +3,203+24.8% | Added |
| Geode Capital Management, LLC | 18,991 | $49.0K | 0.00% | +18,991 | New |
| Pacifica Partners Inc. | 20,585 | $55.0K | 0.04% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 22,553 | $58.0K | 0.01% | +22,553 | New |
| Virtu Financial LLC | 26,016 | $67.0K | 0.01% | +26,016 | New |
| IPG Investment Advisors LLC | 25,900 | $67.1K | 0.02% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 33,215 | $86.0K | 0.02% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 37,517 | $97.0K | 0.00% | +3,853+11.4% | Added |
| Millennium Management LLC | 46,080 | $119.0K | 0.00% | +13,538+41.6% | Added |
| Boothbay Fund Management, LLC | 63,341 | $164.0K | 0.01% | −21,559−25.4% | Reduced |
| Birchview Capital, LP | 70,000 | $181.0K | 0.12% | 00.0% | Unchanged |
| Franklin Street Advisors Inc | 75,100 | $195.0K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 83,090 | $215.0K | 0.00% | −51,193−38.1% | Reduced |
| Bank Julius Baer & Co. Ltd, Zurich | 197,607 | $512.0K | 0.00% | −360.0% | Reduced |
| FNY Investment Advisers, LLC | 318,000 | $823.0K | 0.38% | −25,000−7.3% | Reduced |
| Kingdon Capital Management, L.L.C. | 400,000 | $1.04M | 0.18% | 00.0% | Unchanged |
| Laurion Capital Management LP | 500,000 | $1.29M | 0.02% | 00.0% | Unchanged |
| Great Point Partners LLC | 551,918 | $1.43M | 0.34% | −1,648,082−74.9% | Reduced |
| DAFNA Capital Management LLC | 600,000 | $1.55M | 0.41% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 631,048 | $1.63M | 0.37% | −35,548−5.3% | Reduced |
| Morgan Stanley | 722,975 | $1.87M | 0.00% | −28,318−3.8% | Reduced |
| OrbiMed Advisors LLC | 1,064,118 | $2.76M | 0.03% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 3,285,000 | $8.51M | 0.14% | 00.0% | Unchanged |
| Altium Capital Management LP | 0 | $0 | 0.00% | −161,206−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −85,761−100.0% | Sold out |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 0 | $0 | 0.00% | −49,800−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −46,633−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −23,010−100.0% | Sold out |
| Personal Cfo Solutions, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,836−100.0% | Sold out |
| QS Investors, LLC | – | – | – | – | Not filed |